Gemcitabine and Arabinosylcytosin Pharmacogenomics: Genome-Wide Association and Drug Response Biomarkers

Open Access

Peer-reviewed

Research Article

Liang Li,

Affiliation Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Brooke L. Fridley,

Affiliation Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Krishna Kalari,

Affiliation Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Gregory Jenkins,

Affiliation Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Anthony Batzler,

Affiliation Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Richard M. Weinshilboum,

Affiliation Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Liewei Wang

* E-mail: wang.liewei@mayo.edu

Affiliation Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯

Reader Comments (0)

Introns
Is the Subject Area "Introns" applicable to this article?

Thanks for your feedback.
Single nucleotide polymorphisms
Is the Subject Area "Single nucleotide polymorphisms" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Cytotoxicity
Is the Subject Area "Cytotoxicity" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Genome-wide association studies
Is the Subject Area "Genome-wide association studies" applicable to this article?

Thanks for your feedback.
Pancreatic cancer
Is the Subject Area "Pancreatic cancer" applicable to this article?

Thanks for your feedback.
Genetic polymorphism
Is the Subject Area "Genetic polymorphism" applicable to this article?

Thanks for your feedback.